Somaxon Pharmaceuticals, Inc. (SOMX) - NASDAQ
SOMX is defunct.
From other sites
Company Description
We are a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. We submitted our NDA for Silenor®... More
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: United States